PETER PERDUE - 22 Feb 2026 Form 4 Insider Report for Restaurant Brands International Inc. (QSR)

Signature
/s/ David Wallace, Attorney-in-Fact for Peter Perdue
Issuer symbol
QSR
Transactions as of
22 Feb 2026
Net transactions value
-$262,083
Form type
4
Filing time
24 Feb 2026, 18:29:02 UTC
Previous filing
08 Jan 2026
Next filing
27 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PERDUE PETER President, Popeyes-US & Canada C/O RESTAURANT BRANDS INTERNATIONAL INC, 5707 WATERFORD DISTRICT DRIVE, MIAMI /s/ David Wallace, Attorney-in-Fact for Peter Perdue 24 Feb 2026 0002096961

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QSR Common Shares Options Exercise $0 +9,790 +26% $0.000000 46,788 22 Feb 2026 Direct F1
transaction QSR Common Shares Sale $262,083 -3,882 -8.3% $67.51 42,906 23 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QSR Performance Share Units Options Exercise $0 -12,238 -100% $0.000000 0 22 Feb 2026 Common Shares 12,238 Direct F6
holding QSR Option (Right to Buy) 10,000 22 Feb 2026 Common Shares 10,000 $64.75 Direct F3
holding QSR Option (Right to Buy) 12,000 22 Feb 2026 Common Shares 12,000 $66.31 Direct F3
holding QSR Restricted Share Units 499 22 Feb 2026 Common Shares 499 Direct F4, F5
holding QSR Restricted Share Units 2,166 22 Feb 2026 Common Shares 2,166 Direct F4, F7
holding QSR Performance Share Units 12,083 22 Feb 2026 Common Shares 12,083 Direct F8
holding QSR Restricted Share Units 2,236 22 Feb 2026 Common Shares 2,236 Direct F4, F9
holding QSR Performance Share Units 13,521 22 Feb 2026 Common Shares 13,521 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 2023 PBRSUs vested at 80% of target based on the results of the performance condition.
F2 Represents shares sold to cover withholding tax obligations on the settlement of the vesting of the Reporting Person's performance based restricted share units.
F3 These options are fully vested and exercisable.
F4 Each restricted share unit represents a contingent right to receive one common share.
F5 These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026.
F6 The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs had a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned vested on February 22, 2026. The 2023 PBRSUs vested at 80% of target.
F7 These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027.
F8 The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
F9 These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028.
F10 The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.